What do online grocery shopping, venomous snails, and foot biomechanics have in common? All three were research subjects under investigation at the 2024 DMRC retreat, the largest in the history of the event.
Tag: Diabetes
Metabolic risk factors among people with HIV contributed to new-onset diabetes seen in the REPRIEVE cardiovascular disease prevention trial
An analysis of data from the REPRIEVE statin trial found that metabolic risk factors strongly contributed to the increased cases of new-onset diabetes among people with HIV (PWH).
A new injectable to prevent and treat hypoglycemia
To prevent and treat hypoglycemia, researchers in ACS Central Science report encapsulating the hormone glucagon. In mouse trials, the nanocapsules activated when blood sugar levels dropped dangerously low and quickly restored glucose levels.
Very few patients with abnormal urine protein dipstick results have recommended follow-up testing for early kidney disease
A study of more than 1 million health records found that very few patients with abnormal urine protein dipstick results had follow-up testing for early kidney disease by albuminuria testing as recommended by clinical guidelines.
Study: Time-Restricted Eating May Improve Health of Adults with Metabolic Syndrome
Researchers at UC San Diego School of Medicine find that limiting food consumption within a 10-hour window each day improved key markers of heart health.
Desugared sugarcane extract shows promising antioxidant and antidiabetic properties for nutraceutical applications
A research team reveals the nutraceutical potential of desugared sugarcane extract (DSE), a byproduct of sugar refining, as a rich source of bioactive compounds.
Some Diabetes Drugs Tied to Lower Risk of Dementia, Parkinson’s Disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson’s disease, according to a study published in the September 18, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Egg-White Rice – an Innovative Alternative Food Rich in Nutrients that Appeals to the Health Conscious
Chula Faculty of Allied Health Sciences has launched a ready-to-eat flourless rice innovation made from egg whites, branded as “eggyday”. This product is low in calories, filled with good-quality protein, high in calcium, complete with dietary fibers, and free of gluten.
Primary Care Providers Urged to Assist Patients Who Engage in Emotional Eating
Primary care providers are well positioned to address emotional eating because of their long-term relationships with patients, noted Jana DeSimone Wozniak, PhD and Hsiang Huang, MD, MPH, of Harvard Medical School and Cambridge Health Alliance in Cambridge, Massachusetts.
New technology ‘lights up’ bacteria in wounds for better infection prevention
New Keck Medicine of USC research published in Advances in Wound Care suggests there may be a more effective method to detect bacteria during wound debridement.
Mount Sinai Health System Researcher Receives $4 Million Grant From NIH to Study the Role of the Mammary Gland Secretome in Metabolic Health
Investigating a new frontier in understanding diseases like obesity and type 2 diabetes.
Mental health and chronic diabetes complications strongly linked both ways, study finds
When a person has chronic diabetes complications – such as heart attack, stroke and nerve damage – they are more likely to have a mental health disorder, and vice versa, according to a study. Researchers say the findings highlight a need for clinicians to actively screen for mental health disorders in patients with diabetes in addition to screening for chronic complications, which is the recommended standard of care in diabetes.
Type 2 diabetes increased by almost 20% over a decade
Type 2 diabetes increased by almost 20% between 2012 and 2022, according to a new study from the University of Georgia.
Deadly Sea Snail Toxin Could be Key to Making Better Medicines
Scientists are finding clues for how to treat diabetes and hormone disorders in an unexpected place: a toxin from one of the most venomous animals on the planet.
25th Annual Diabetes Seminar
DIABETES & COGNITIVE DECLINE – Learn How to Reduce Your Risk
Joslin Diabetes Center Investigator Rohit N. Kulkarni, MD, PhD, Awarded $10 Million NIH/NIDDK Grant for Pioneering Diabetes and Obesity Research
Rohit N. Kulkarni, MD, PhD, the Diabetes Research and Wellness Foundation Endowed Chair and Co-Head of the Section on Islet & Regenerative Biology at Joslin Diabetes Center, has been awarded $9,920,607 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).
Low magnesium levels increase disease risk, new study shows
A new Australian study has identified why a diet rich in magnesium is so important for our health, reducing the risk of DNA damage and chronic degenerative disorders.
Cleveland Clinic Study Adds to Increasing Evidence that Sugar Substitute Erythritol Raises Cardiovascular Risk
New Cleveland Clinic research shows that consuming foods with erythritol, a popular artificial sweetener, increases risk of cardiovascular events such as heart attack and stroke. The findings, from a new intervention study in healthy volunteers, show erythritol made platelets (a type of blood cell) more active, which can raise the risk of blood clots.
The Medical Minute: The truth about diabetes
Type 1? Type 2? Do you have to take injections for the rest of your life? A Penn State Health expert discusses diabetes and how there are more options than ever to beat it.
Texas Tech Health El Paso Associate Professor Receives Prestigious NIH Grant to Investigate Cause of Diabetic Pain
Researchers at Texas Tech Health El Paso and the University of Texas at Dallas will look at the origin of this neuropathic pain on a microscopic level in hope of finding ways to treat it without opioids. The groundbreaking research is funded by a $3.1 million, five-year R01 grant from the National Institutes of Health (NIH). Texas Tech Health El Paso is receiving $1.05 million of the grant.
Study Uncovers Connections Between Obesity and Heart Failure
A new small study led by Johns Hopkins Medicine researchers and published July 25th in the journal Nature Cardiovascular Research has revealed the impact of obesity on muscle structure in patients having a form of heart failure called heart failure with a preserved ejection fraction (HFpEF).
Roche showcases solutions for laboratories of the future at the Association for Diagnostics & Laboratory Medicine 2024 Clinical Lab Expo
● Roche will unveil the next generation of core lab and molecular systems, including a total solution for clinical mass spectrometry.
● Attendees can experience firsthand how fully integrated systems and data solutions can streamline lab operations, optimize resources and expedite care.
New study shows popular diabetes and weight-loss drugs associated with lower risk for tobacco-use disorder
A new study by researchers at the Case Western Reserve School of Medicine reveals popular diabetes and weight-loss drugs are linked to a lower risk for tobacco-use disorder (TUD) in smokers with type 2 diabetes, compared with seven other anti-diabetes medications.
BePRECISE consortium unveils guidelines to enhance reporting in precision medicine research
The inaugural reporting guidelines for precision medicine research, of which Wits University Professor Michèle Ramsay is co-author, have been published in Nature Medicine.
UTSW study identifies RNA molecule that regulates cellular aging
A team led by UT Southwestern Medical Center researchers has discovered a new way that cells regulate senescence, an irreversible end to cell division.
Advanced nanofibrous membranes: tackling diabetic wounds with precision
In a pioneering study, researchers have developed a poly (L-lactic acid) (PLLA) nanofibrous membrane enhanced with curcumin and silver nanoparticles (AgNPs), aimed at improving the healing of diabetic wounds.
Engineered nanovesicles from activated neutrophils show promise in treating infected wounds
A recent study has developed nanovesicles (NVs) from activated neutrophils, showcasing their ability to perform molecular debridement and accelerate healing in infectious wounds. This novel method significantly enhances treatment effectiveness, particularly for stubborn diabetic wounds, by targeting and neutralizing deep tissue pathogens.
Cedars-Sinai Vuelve a Figurar Entre los Mejores Hospitales de EE.UU.
Cedars-Sinai ha sido incluido en la Lista de Honor por noveno año consecutivo en la clasificación “Mejores hospitales 2024-25” por el U.S. News & World Report.
Cedars-Sinai Again Ranked in Top Tier of U.S. Hospitals
Cedars-Sinai has been named to the Honor Roll for the ninth consecutive year in U.S. News & World Report’s “Best Hospitals 2024-25” rankings.
UT Southwestern once again ranked best hospital in DFW
UT Southwestern Medical Center is the No. 1 hospital in Dallas-Fort Worth for the eighth consecutive year and ranks among the nation’s top hospitals for care in 11 specialties – the most of any hospital in Texas, according to U.S. News & World Report’s annual Best Hospitals list released today.
GLP-1RAs not associated with increased risk for suicidal thoughts or behaviors
A target trial emulation study found no increased risk for suicidal thoughts or behaviors associated with the use of GLP-1RAs (glucagon-like peptide-1 receptor agonists) to treat type 2 diabetes (T2D).
Are GLP-1 drugs safe for children? Doctors say despite high use among youth, no unique health risks detected
With the skyrocketing popularity of weight-loss drugs like Ozempic, Wegovy, and Mounjaro, health experts are noticing an increasing trend of use among younger Americans. According to new findings published in the Journal of the American Medical Association, the number of teens and young adults prescribed…
Mount Sinai and City of Hope Scientists First to Demonstrate a Combination Treatment Can Increase Human Insulin-Producing Cells in Vivo
Research published in Science Translational Medicine advances therapies to regenerate beta cells as a potential new treatment for diabetes
Study Suggests States Could Cut Healthcare Costs by Delivering Patient Tailored Meals
According to new research looking at every U.S. state, programs that deliver medically tailored meals (MTMs) to people with diet-sensitive conditions such as diabetes and heart disease along with limitations in the ability to perform daily activities could lead to substantial savings in healthcare costs.
Research Uncovers Heart-Protective Eating Patterns for Type 1 Diabetes
Eating patterns that align with the Mediterranean diet or the dietary approaches to stop hypertension (DASH) diet could help lower cardiovascular disease risk in adults with type 1 diabetes, according to results from a six-year study.
Compound from Olives Shows Promise for Treating Obesity and Diabetes
Findings from a new mouse study suggest that elenolic acid, a natural compound found in olives, can lower blood sugar levels and promote weight loss. The research could pave the way to the development of safe and inexpensive natural products for managing obesity and type 2 diabetes in people.
Master autoimmune regulator gets by with a little help from its friends
See how St. Jude researchers investigated Foxp3 function as a transcription cofactor in regulatory T cells in immune system activation and suppression.
Gene Variant May Underlie Diabetes Disparities: Study
A genetic variation common in people of African ancestry is associated with an increased risk of complications from diabetes, including diabetic retinopathy, according to a report published June 25 in the journal Nature Medicine.
From the Pakistan-India Border to Our Borderplex: A Doctor’s Journey Dr. Muhammad Moiz Tahir tackles El Paso’s health challenges with community-driven care
EL PASO, Texas — Some people claim borders are barriers. Others see them as frontiers worthy of exploration. Muhammad Moiz Tahir, M.D., is one of the newest assistant professors in the Foster School of Medicine’s Department of Internal Medicine. Dr.…
NUTRITION 2024 Press Materials Available Now
Press materials are now available for NUTRITION 2024, the annual flagship meeting of the American Society for Nutrition (ASN). Top nutrition scientists and practitioners from around the world will gather to share the latest research findings on food and nutrition during the meeting in Chicago from June 29–July 2.
How Your Sleep Patterns Change Can Tell You About Your Health
Your sleep tracker might give you information about more than just your sleep–specifically, it might give you information about chronic conditions such as diabetes and sleep apnea, and illnesses such as COVID-19. This is one of the findings of a study that analyzed data from 5 million nights of sleep across roughly 33,000 people.
NUTRITION 2024 showcases groundbreaking research on what we eat and why it matters
Be among the first to hear breaking news in food and nutrition science at NUTRITION 2024, the annual flagship meeting of the American Society for Nutrition held June 29–July 2 at McCormick Place in Chicago.
Retrospective Study Based on Electronic Health Records Finds Popular Diabetes and Weight-Loss Drugs Associated with Reduction in Incidence and Recurrence of Alcohol-Use Disorder by at Least Half
A new study by researchers at the Case Western Reserve University School of Medicine reveals that the popular diabetes and weight-loss drugs Wegovy and Ozempic are linked to reduced incidence and recurrence of alcohol abuse or dependence.
Telemedicine may increase endocrinology care access for under-resourced patients with diabetes and heart disease
Widespread availability of telemedicine during the pandemic led to more equitable access to endocrinology care for patients with type 2 diabetes and heart disease, according to a study being presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Two medication classes reduced cardiovascular and liver events in people with type 2 diabetes
GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Metformin may be as safe as insulin during pregnancy, 11-year data shows
Metformin is safe to use during pregnancy to manage diabetes, with no long-term adverse effects on the children born and their mothers for at least 11 years after childbirth, according to research presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. This is the first study to look at longer term effects of metformin use during pregnancy.
High insulin levels contribute to worse outcomes for Black women with aggressive form of breast cancer
High insulin levels contribute to worse outcomes for Black women compared to white women who have an aggressive form of breast cancer called triple-negative breast cancer, according to a study presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Anti-obesity medication tirzepatide remains effective even for those with diabetes and other complications
Having medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide, according to an industry-supported study being presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Race and social vulnerability impact glycemic control in people with diabetes
People of color and those who experience social vulnerability are more likely to experience worse glycemic control than their white counterparts, according to research presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
A nanomaterial one-two punch quickly heals wounds in diabetic animal model
Wounds that are superficial for some can be life-threatening for others. With diabetic wounds, healing can be slow, particularly in the feet, increasing the tissue’s susceptibility to infection. Foot ulcers and other diabetic foot complications have similar mortality rates to some cancers, yet progress toward improved treatments has plateaued.